Error: Could not add to watchlist. X

Clovis Oncology Inc

+ Watchlist
CLVS:US
NASDAQ GS
82.81
USD
4.19
4.82%
As of 20:10:00 ET on 06/02/2015.
Open
86.53
Day Range
82.52 - 86.90
Volume
1,065,377
Previous Close
87.00
52Wk Range
35.33 - 102.28
1 Yr Return
116.61%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-5.67
Market Cap (b USD)
2.821
Shares Outstanding (m)
34.065
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech
Profile
Clovis Oncology Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. Clovis target its development programs for the treatment of specific subsets of cancer populations.
ADDRESS
2525 28th Street
Suite 100
Boulder, CO 80301
United States
PHONE
1-303-625-5000
  • Patrick J Mahaffy
    President/CEO/Co-Founder
  • Erle T Mast
    Exec VP/CFO/Secy/Co-Founder
  • Steven L Hoerter
    Exec VP/Chief Commercial Ofcr
  • Andrew R Allen
    Exec VP:PRE-Clinical Dev
Show More